CCL5 and Hypofibrinogenemia: The increase in CCL-5 levels in patients who presented hypofibrinogenemia may be associated with a possible action of the generated thrombin and FXa, since these factors are responsible for the expression of this chemokine in fibroblasts, platelets, and endothelial cells (76–78).